|
the influence of urine bisphenol a levels on hypergonadotropic hypogonadal state in type 2 diabetic males
|
14-04-202213-10-2024
|
Ketua Projek
|
|
investigating the cardiovascular changes in normotensive and hypertensive young adults
|
01-10-202230-09-2024
|
Penyelidik Bersama
|
|
the effects of weekly glucagon-like peptide-1 receptor agonist (glp-1 ra) semaglutide on glycaemic variability in subjects with type 2 diabetes mellitus and end stage renal disease
|
09-12-202108-09-2024
|
Ketua Projek
|
|
elucidation of vitamin d levels and heart rate variability infleunce on endothelial function via renin angiotensin aldosterone system augmention in obstructive sleep apnea
|
07-09-202106-09-2024
|
Penyelidik Bersama
|
|
an integrated word embeddings and semantic linguistic features approach for electronic medical record classification
|
07-09-202106-09-2024
|
Penyelidik Bersama
|
|
time-to-adrenalectomy for diagnosis and treatment of primary aldosteronism: a retrospective study
|
22-06-202321-04-2024
|
Ketua Projek
|
|
-
|
15-02-202214-02-2024
|
Ketua Projek
|
|
identifying healthcare gaps, limitations and challenges faced in various asean countries when managing hypertension and primary aldosteronism
|
09-02-202308-02-2024
|
Ketua Projek
|
|
elucidating the role of aldosterone production on cell proliferation and apoptosis
|
28-11-201927-11-2023
|
Penyelidik Bersama
|
|
discerning a biomarker for complete cure of hypertension post-adrenalectomy among primary aldosteronism patients
|
01-09-201931-10-2023
|
Penyelidik Bersama
|
|
-
|
01-07-202130-06-2023
|
Ketua Projek
|
|
identification of putative protein profiles associated with tamoxifen therapy effectiveness in residual non-functioning pituitary neuroendocrine tumors
|
30-03-201929-03-2023
|
Ketua Projek
|
|
smart wearable device for detection and classification of diabetes polyneuropathy severity
|
01-10-202131-12-2022
|
Penyelidik Bersama
|
|
discerning the genetic contributors to autonomous aldosterone production through whole genome sequencing
|
01-01-202031-12-2022
|
Penyelidik Bersama
|
|
the role of selectively expressed zona glomerulosa (zg) genes on aldosterone and cell function in physiological and pathological adaptation to salt excess
|
11-01-201830-09-2022
|
Penyelidik Bersama
|
|
a randomised double blind placebo controlled trial on the effectiveness of probiotic on the lipid parameters in young type 2 diabetic patients
|
04-06-202103-08-2022
|
Ketua Projek
|
|
randomized,24 week,active-controlled,open-label,3-arm.parallel-group multicenter study comparing the efficacy and safety of iglarlixi to insulin glargine and lixisenatide in type 2 diabetes mellitus patients insufficiently controlled with oral antidiabet
|
13-09-201912-07-2022
|
Penyelidik Bersama
|
|
the role of blue-tooth technology, smart phone application and remote diabetes management in reduction of hba1c in type 2 diabetes mellitus patients on intensive insulin regimen
|
08-04-202107-02-2022
|
Ketua Projek
|
|
efficacy of wf10 in treatment of diabetic neuropathic wound: a prospective controlled study
|
01-02-202125-01-2022
|
Penyelidik Bersama
|
|
safety and efficacy of wf10 for diabetes-related vascular diseases: a prospective controlled study
|
26-06-202025-01-2022
|
Penyelidik Bersama
|
|
a randomized controlled clinical trial on the effectiveness of lithium in comparison to carbimazole as a bridging therapy prior to radioactive iodine for hyperthyroidism
|
10-01-202109-01-2022
|
Ketua Projek
|
|
a randomized, multicountry, multicenter, double-blind, parallel, placebo-controlled study of the effects of atrasentan on renal outcomes in subjects with type 2 diabetes and nephropathy
sonar: study of diabetic nephropathy with atrasentan
|
24-11-201323-09-2021
|
Ketua Projek
|
|
knowledge of chronic kidney disease and its associated factors among university students in klang valley
|
11-06-202010-09-2021
|
Penyelidik Bersama
|
|
the use of serum free triiodothyronine : free thyroxine ratio in differentiating gestational transient hyperthyroxinemia from grave’s disease in pregnancy
|
09-07-202008-07-2021
|
Ketua Projek
|
|
discover global registry
|
16-05-201915-05-2021
|
Ketua Projek
|
|
developing core outcome sets of patients with thyroid dysfunction and complex type 2 diabetes mellitus/thyroid dysfunctions multimorbidity
|
28-11-201927-04-2021
|
Penyelidik Bersama
|
|
comparative study of incretin system and its association with insulin resistance in three ethnic groups with abnormal glucose tolerance
|
16-10-201715-04-2021
|
Penyelidik Bersama
|
|
dar global survey on diabetes in ramadan during covid-19 era
|
13-08-202012-02-2021
|
Penyelidik Bersama
|
|
prevalence of hypogonadism among type 2 diabetic males attending diabetes clinic and primary healthcare clinic in ppukm (mytestodm study)
|
27-06-201926-12-2020
|
Penyelidik Bersama
|
|
comparative study of incretin system and its association with insulin resistance in three ethnic groups with abnormal glucose tolerance
|
10-08-201709-08-2020
|
Penyelidik Bersama
|
|
tecos: a randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with sitagliptin in patients with type 2 diabetes mellitus and inadequate glycemic
|
01-08-200931-07-2020
|
Penyelidik Bersama
|
|
advancing care of adrenal disease and adrenal registry in asia (adrenal asia)
|
29-03-201828-06-2020
|
Ketua Projek
|
|
effects of oral calcitriol in the treatment of biopsy proven immunoglobulin a nephropathy: randomised control clinical study
|
25-09-201824-03-2020
|
Penyelidik Bersama
|
|
the prevalence of low renin hypertension and primary aldosteronism among three major ethnic groups in malaysia
|
13-05-201912-11-2019
|
Ketua Projek
|
|
association of single nucleotide polymorphisms of cyp11b2, cyp11b1 and cyp17a1 with primary aldosteronism in a multiethic malaysian cohort
|
10-05-201809-11-2019
|
Penyelidik Bersama
|
|
progression of kidney disease and cardiovascular outcomes in patients with non-diabetic chronic kidney disease over a four-year period
|
13-09-201812-09-2019
|
Ketua Projek
|
|
a 5 year study to compare the durability of glycemic control of a combination regimen of vildagliptin & metformin versus standard-of-care monotherapy with metformin, initiated in treatm
|
01-08-201231-07-2019
|
Penyelidik Bersama
|
|
histopathological-specific mutation spectrum of primary aldosteronism in ukmmc
|
28-04-201627-04-2019
|
Penyelidik Bersama
|
|
primary aldosteronism in malaysia : a nation-wide multicentre study
|
24-04-201423-04-2019
|
Ketua Projek
|
|
a multicentre, randomized, double-blind, placebo-controlled, phase 3 study to evaluate cardiovascular outcomes of tak-875, 50 mg in addition to standard of care in subjects with 2 diabetes and with cardiovascular disease or multiple risk for cardiovascular
|
01-01-201331-03-2019
|
Ketua Projek
|
|
the effect of vitamin d treatment on clinical and biochemical outcomes of primary aldosteronism
|
13-09-201812-03-2019
|
Ketua Projek
|
|
a phase iii, multicentre, international, randomised, parallel grooup, double blind cardiovascular safety study of bi 10773 compared to usual care
|
01-11-201028-02-2019
|
Penyelidik Bersama
|
|
pilot genome wide association study (gwas) of primary aldosteronism
|
01-01-201731-12-2018
|
Penyelidik Bersama
|
|
dose escalation study of empagliflozin a sodium glucose transporter 2 (sglt2) inhibitor, in type 2 dm who are not well controlled on existing oral antidiabetic agents
|
18-11-201717-11-2018
|
Penyelidik Bersama
|
|
genetic study on aldosterone-producing adenomas (apas) in the multiethnic population of malaysia
|
02-11-201501-10-2018
|
Penyelidik Bersama
|
|
pilot genome wide association study (gwas) on primary aldosteronism in the multiethnic population of malaysia
|
11-08-201610-08-2018
|
Penyelidik Bersama
|
|
24-h urinary tetrahydroaldosterone test compared to fludrocortisone suppression test in diagnosing primary aldosteronism
|
14-05-201513-05-2018
|
Ketua Projek
|
|
the genetics of adrenal gland diseases causing hyoertension
|
01-05-201530-04-2018
|
Penyelidik Bersama
|
|
non invasive follicular variant of papillary thyroid carcinoma and papillary thyroid microcarcinoma versus other subtype of papillary thyroid carcinoma : an audit on clinical outcome
|
25-01-201824-02-2018
|
Penyelidik Bersama
|
|
a rondomized double-blind placebo-controlled, multicenter study to assess cardiovaskular outcomes following treatment with mk-3102 in subjects with type 2 diabetes mellitus
|
01-05-201331-12-2017
|
Penyelidik Bersama
|
|
hypertension and type 2 diabetes mellitus among young adults
|
31-12-201430-12-2017
|
Ketua Projek
|
|
a multicenter, international, randomized, parallel group, double blind, placebo-controlled cardiovascular safety & renal microvascular outcome with linagliptin, 5 mg once daily in patients with type 2 diabetes mellitus at high vascular risk. carmelina
|
20-11-201322-12-2017
|
Penyelidik Bersama
|
|
a randomized multicenter, double-blind, parallel, placebo-controlled study of the effects of jnu-28431754 on cardiovascular outcomes in adult subjects with type 2 diabetes
|
01-05-201030-11-2017
|
Ketua Projek
|
|
a comparative study of neruo-fuzzy logic algorithm versus standard sliding scale algorithm for insulin infusion adjustment in hospitalized patients with hyperglycaemia
|
27-10-201626-10-2017
|
Penyelidik Bersama
|
|
nn5401-4243 : a trial comparing efficacy and safety of insulin degludec/insulin aspart twice daily and biphasic insulin aspart twice daily in subjects with type 2 diabetes mellitus before, during and after ramadan
|
04-01-201631-08-2017
|
Penyelidik Bersama
|
|
a multicentre, randomized, double-blind, placebo-controlled, phase 3 study to evaluate cardiovascular outcomes of tak-875 mg in addition to standard of care in subjects with 2 diabetes and with cardiovascular disease or multiple risk for cardiovascular
|
01-04-201531-03-2017
|
Ketua Projek
|
|
a phase iii randomised, double-blind, active-controlled, parallel group efficacy and safety study of bi 10773 compared to glimepiride administered orally during 104 weeks in patients
|
01-11-201030-11-2016
|
Penyelidik Bersama
|
|
a phase 3, randomized, active comparator, double-blind, multi-center study to compare the efficacy, safety and tolerability of itca 650 to sitagliptin as add-on therapy to metformin in patients with type 2 diabetes
|
01-08-201301-08-2016
|
Penyelidik Bersama
|
|
thyroid disorders in malaysia : a nationwide multicentre study
|
26-06-201425-06-2016
|
Penyelidik Bersama
|
|
exome sequencing for somatic mutations in aldosterone-producing adenomas
|
01-06-201531-05-2016
|
Penyelidik Bersama
|
|
a prospective prevalence study of functional adrenal insufficiency and its outcome in accute myocardial infarction in ukmmc
|
16-04-201415-12-2015
|
Penyelidik Bersama
|
|
a prospective prevalence study of functional adrenal insufficiency and its outcome in acute myocardial infarction in ukmmc
|
01-12-201430-11-2015
|
Penyelidik Bersama
|
|
the effect of disease-specific treatment on bone turnover markers in primary aldosteronism in asian population
|
15-06-201414-06-2015
|
Ketua Projek
|
|
renin and aldosterone levels in various stages of non diabetic chronic kidney disease
|
01-06-201431-05-2015
|
Ketua Projek
|
|
identification of the hormonal factors associated with improvement of cardiac morphology in morbidly obese patients who had undergone bariatric surgery
|
24-11-201423-05-2015
|
Penyelidik Bersama
|
|
a phase 3, multicenter, randomized, double-blind, active-controlled, 24-week study to evaluate the efficacy and safety of daily oral tak-875 50mg compared with sitagliptin 100 mg when used in combination with metformin in subjects with type 2 diabetes
|
31-01-201431-03-2015
|
Ketua Projek
|
|
a multicenter, randomized, double-blind, active-controlled, phase 3 study to evaluate the efficacy and safety of tak-875 25mg and 50 mg compared to glimepiride when used in combinati
|
01-06-201231-12-2014
|
Penyelidik Bersama
|
|
lira-ramadan™ . efficacy and safety of liraglutide versus sulphonylurea both in combination with metformin during ramadan in subjects with type 2 diabetes. trial phase : 4
|
09-01-201431-08-2014
|
Penyelidik Bersama
|
|
a multicenter, randomized, double-blind, placebo- and active-controlled, phase 3 study to evaluate the efficacy and safety of tak-875 25mg, and 50mg compared to placebo and sitagliptin 100mg when used in combination with metformin in subjects with type 2 diabetes
|
01-10-201331-05-2014
|
Penyelidik Bersama
|
|
a randomised trial comparing efficacy and safety after intensification with either insulin aspart once daily as add-on or changing to basal bolus treatment with insulin degludec and insulin aspart in subjects with type 2 diabetes previously treated with i
|
01-07-201331-05-2014
|
Penyelidik Bersama
|
|
diabcare asia 2012 – malaysia. a cross-sectional survey to evaluate diabetes management, control, complications, psychosocial aspects of patients with type 2 diabetes in malaysia
|
01-05-201331-08-2013
|
Penyelidik Bersama
|
|
an international survey on hypoglycaemia among insulin-treated patients with diabetes (hat study)
|
01-05-201331-08-2013
|
Penyelidik Bersama
|
|
a trial comparing the efficacy and safety of two different titration algorithms for insulin degludec/insulin aspart in subjects with type 2 diabetes mellitus previously treated with in
|
01-09-201231-07-2013
|
Penyelidik Bersama
|
|
bantuan kewangan bahan penyelidikan: norlela binti sukor
|
12-09-201228-02-2013
|
Penyelia
|
|
self-care practices, health beliefs and glycemic control in young adults with type 1 diabetes
|
01-07-201031-12-2012
|
Penyelidik Bersama
|
|
observational study to analyze in daily clinical practice the titration scheme of the new diamicron mr 60 mg formulation in a large uncontrolled type 2 diabetic population
|
01-05-201230-11-2012
|
Penyelidik Bersama
|
|
a phase iii, multicenter, randomized, open-label clinical trial comparing the efficacy and safety of mk431a (the fixed-dose combination of sitagliptin and metformin)
|
01-03-201130-11-2012
|
Penyelidik Bersama
|
|
efficacy of pentoxyfylline in reducing proteimuria in diabetic kidney disease when added to standard therapy
|
01-02-201231-10-2012
|
Ketua Projek
|
|
effects of hyperaldosteronism on cardiovascular autonomic function in primary aldosteronism
|
01-10-201131-08-2012
|
Ketua Projek
|
|
a randomized, double-blind, placebo-controlled, parallel-group, 26-week, multicenter study with a 26 week extension to evaluate the efficacy, safety and tolerability of jnj-28431754 (canagliflozin) as a monotherapy in the treatment
|
01-06-201031-08-2012
|
Penyelidik Bersama
|
|
a randomized, double-blind, placebo and active-controlled, 4-arm, parallel-group, multicenter study to evaluate the efficacy, safety and tolerability of jnj-28431754 (canagliflozin) compared w
|
01-06-201031-05-2012
|
Penyelidik Bersama
|
|
dual 1: dual action of liraglutide and insulin deglydec in type 2 diabetes
|
01-05-201130-04-2012
|
Penyelidik Bersama
|
|
a randomized, placebo-controlled, 2 arm parallel-group, multicenter study with a 24 week double-blind treatment period assessing the efficacy and safety of lexisenatide in patients with type 2 diabetes
|
01-12-200931-12-2011
|
Penyelidik Bersama
|
|
begin: once asia: a pan asian trial comparing efficacy and safety of insuln nn1250 and insulin glargine as add on to oad(s) in subjects with type 2 diabetes
|
01-03-201031-12-2010
|
Penyelidik Bersama
|
|
-
|
11-09-2023
|
Ketua Projek
|
|
tabung agihan penyelidikan (tap)-k013181
|
22-12-2021
|
Penyelia
|